SCHEMBL31052438

SCHEMBL31052438

CCc1c[nH]nc1Nc1ncc(C(=O)Nc2c(C)ccc(O)c2C)s1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 16/20 0.46
▸ MAPK14 Q16539 6/20 0.45
▸ MAPK13 O15264 2/20 0.40
▸ EGFR P00533 2/20 0.40
▸ FYN P06241 2/20 0.40
▸ HCK P08631 2/20 0.40
▸ SRC P12931 2/20 0.40
▸ JAK3 P52333 2/20 0.40
▸ MAPK12 P53778 2/20 0.40
▸ MAPK11 Q15759 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ ERBB2 P04626 1/20 0.40
▸ YES1 P07947 1/20 0.40
▸ LYN P07948 1/20 0.40
▸ FGR P09769 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ BCR P11274 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31052523 0.88 LCK (0.46) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052645 0.88 LCK (0.46) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052617 0.79 LCK (0.46) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052727 0.79 LCK (0.50) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31704600 0.79 LCK (0.51) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052513 0.79 LCK (0.50) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31705253 0.79 LCK (0.51) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052676 0.76 MAPK14 (0.55) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052442 0.74 LCK (0.44) LCKMAPK14MAPK13EGFRFYN
SCHEMBL31052616 0.73 MAPK14 (0.47) LCKMAPK14MAPK13EGFRFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676923-A1 BIARYLAMIDE DERIVATIVES AND THEIR USE AS PKMYT1 INHIBITORS Cancer Research Technology Limited (GB) 2026-01-14 — — EP disclosed
WO-2024184550-A1 BIARYLAMIDE DERIVATIVES AND THEIR USE AS PKMYT1 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-09-12 — — WO disclosed
Send feedback